Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aluminium acetotartrate is a topical astringent and antiseptic compound formed as the aluminium salt of acetic and tartaric acids. It is primarily used in dermatology and otology for its ability to precipitate proteins, which provides astringent, antimicrobial, and pH-stabilizing effects. Developed and marketed by companies like Athenstaedt, it is used to treat a wide range of conditions including skin irritations, wounds, external ear infections (otitis externa), diaper rash, and inflammatory mucosal conditions. It is commonly formulated as solutions for wet compresses, ointments, or rinses, and is recognized in various pharmacopoeias including the DAB.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aluminium acetotartrate (Athenstaedt).